Categories Analysis, Consumer

Key takeaways from Procter & Gamble’s (PG) Q2 2024 earnings report

For fiscal year 2024, P&G expects organic sales growth of 4-5%

Shares of Procter & Gamble (NYSE: PG) gained over 4% on Tuesday despite the company posting mixed results for the second quarter of 2024. Earnings beat expectations while revenue fell short of estimates. The consumer goods firm also lowered its full-year earnings guidance due to an impairment charge. Here are the key takeaways from the earnings report:

Mixed results

Procter & Gamble’s net sales in Q2 2024 grew 3% year-over-year to $21.44 billion, but narrowly missed estimates. Organic sales rose 4%, helped by higher pricing, partly offset by a 1% drop in shipment volumes. GAAP EPS decreased 12% to $1.40, mainly due to an impairment charge related to its Gillette business. Core EPS grew 16% to $1.84, surpassing expectations.

Category performance

P&G saw sales growth across all its segments during the second quarter, both on a reported and organic basis. Organic sales in the Beauty segment grew 1% YoY, with high-single-digit growth in Hair Care, driven by higher pricing, product mix, and volume growth. However, volume declines and unfavorable mix led to a mid-single-digits sales decline in Skin and Personal Care.

Organic sales in Grooming rose 9%, driven by higher pricing, premium product mix and volume growth. The Health Care segment witnessed organic sales growth of 2%, with mid-single-digit growth in Oral Care. Personal Health Care organic sales fell in the low single digits, hurt by a decline in respiratory products.

Fabric and Home Care saw organic sales grow 6%, with mid-single-digit growth in Fabric Care and high-single-digit growth in Home Care. Baby, Feminine and Family Care saw organic sales growth of 3%.

Outlook

For fiscal year 2024, P&G expects all-in sales growth of 2-4% and organic sales growth of 4-5%. The company revised its outlook for GAAP EPS and now expects it to be down 1% to flat versus last year. The previous expectation was for a growth of 6-9%. The updated earnings guidance reflects the Gillette impairment charge and a restructuring program announced last month.

PG raised its core EPS guidance for the year based on strong quarterly performance. Core EPS is now expected to grow 8-9% YoY versus the prior range of 6-9%. This amounts to a range of $6.37-6.43 per share.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top